164 related articles for article (PubMed ID: 24016805)
21. Genome-Wide CRISPR Screen Identifies Semaphorin 6A and 6B as Receptors for Paeniclostridium sordellii Toxin TcsL.
Tian S; Liu Y; Wu H; Liu H; Zeng J; Choi MY; Chen H; Gerhard R; Dong M
Cell Host Microbe; 2020 May; 27(5):782-792.e7. PubMed ID: 32302524
[TBL] [Abstract][Full Text] [Related]
22. Expression of the large clostridial toxins is controlled by conserved regulatory mechanisms.
Carter GP; Larcombe S; Li L; Jayawardena D; Awad MM; Songer JG; Lyras D
Int J Med Microbiol; 2014 Nov; 304(8):1147-59. PubMed ID: 25190355
[TBL] [Abstract][Full Text] [Related]
23. Fatal Clostridium sordellii-mediated hemorrhagic and necrotizing gastroenteropathy in a dog: case report.
Capewell P; Rupp A; Fuentes M; McDonald M; Weir W
BMC Vet Res; 2020 May; 16(1):152. PubMed ID: 32448314
[TBL] [Abstract][Full Text] [Related]
24. Comparative genomic and phenomic analysis of Clostridium difficile and Clostridium sordellii, two related pathogens with differing host tissue preference.
Scaria J; Suzuki H; Ptak CP; Chen JW; Zhu Y; Guo XK; Chang YF
BMC Genomics; 2015 Jun; 16(1):448. PubMed ID: 26059449
[TBL] [Abstract][Full Text] [Related]
25. [Investigation of toxin genes of Clostridium difficile strains isolated from hospitalized patients with diarrhoea at Marmara University Hospital].
Deniz U; Ulger N; Aksu B; Karavuş M; Söyletir G
Mikrobiyol Bul; 2011 Jan; 45(1):1-10. PubMed ID: 21341153
[TBL] [Abstract][Full Text] [Related]
26. Comparison of Clostridium sordellii toxins HT and LT with toxins A and B of C. difficile.
Martinez RD; Wilkins TD
J Med Microbiol; 1992 Jan; 36(1):30-6. PubMed ID: 1370542
[TBL] [Abstract][Full Text] [Related]
27. Cloning and expression of Clostridium difficile toxin A gene (tcdA) by PCR amplification and use of an expression vector.
Ackermann G; Löffler B; Tang-Feldman YJ; Cohen SH; Silva J; Rodloff AC
Mol Cell Probes; 2004 Aug; 18(4):271-4. PubMed ID: 15271388
[TBL] [Abstract][Full Text] [Related]
28. A novel fusion protein containing the receptor binding domains of C. difficile toxin A and toxin B elicits protective immunity against lethal toxin and spore challenge in preclinical efficacy models.
Tian JH; Fuhrmann SR; Kluepfel-Stahl S; Carman RJ; Ellingsworth L; Flyer DC
Vaccine; 2012 Jun; 30(28):4249-58. PubMed ID: 22537987
[TBL] [Abstract][Full Text] [Related]
29. Recognition of Semaphorin Proteins by P. sordellii Lethal Toxin Reveals Principles of Receptor Specificity in Clostridial Toxins.
Lee H; Beilhartz GL; Kucharska I; Raman S; Cui H; Lam MHY; Liang H; Rubinstein JL; Schramek D; Julien JP; Melnyk RA; Taipale M
Cell; 2020 Jul; 182(2):345-356.e16. PubMed ID: 32589945
[TBL] [Abstract][Full Text] [Related]
30. Specific detection of Clostridium difficile toxin A gene sequences in clinical isolates.
Tang YJ; Gumerlock PH; Weiss JB; Silva J
Mol Cell Probes; 1994 Dec; 8(6):463-7. PubMed ID: 7700267
[TBL] [Abstract][Full Text] [Related]
31. Metal Ion Activation of Clostridium sordellii Lethal Toxin and Clostridium difficile Toxin B.
Genth H; Schelle I; Just I
Toxins (Basel); 2016 Apr; 8(4):109. PubMed ID: 27089365
[TBL] [Abstract][Full Text] [Related]
32. The large clostridial toxins from Clostridium sordellii and C. difficile repress glucocorticoid receptor activity.
Tait AS; Dalton M; Geny B; D'Agnillo F; Popoff MR; Sternberg EM
Infect Immun; 2007 Aug; 75(8):3935-40. PubMed ID: 17517870
[TBL] [Abstract][Full Text] [Related]
33. Large Clostridial Toxins: Mechanisms and Roles in Disease.
Orrell KE; Melnyk RA
Microbiol Mol Biol Rev; 2021 Aug; 85(3):e0006421. PubMed ID: 34076506
[TBL] [Abstract][Full Text] [Related]
34. Comparative analysis of the extracellular proteomes of two Clostridium sordellii strains exhibiting contrasting virulence.
Kachman MT; Hurley MC; Thiele T; Srinivas G; Aronoff DM
Anaerobe; 2010 Aug; 16(4):454-60. PubMed ID: 20338254
[TBL] [Abstract][Full Text] [Related]
35. Difference in protein substrate specificity between hemorrhagic toxin and lethal toxin from Clostridium sordellii.
Genth H; Hofmann F; Selzer J; Rex G; Aktories K; Just I
Biochem Biophys Res Commun; 1996 Dec; 229(2):370-4. PubMed ID: 8954906
[TBL] [Abstract][Full Text] [Related]
36. Antibodies against recombinant catalytic domain of lethal toxin of Clostridium sordellii neutralize lethal toxin toxicity in HeLa cells.
Arya P; Ponmariappan S; Singh L; Prasad GB
Protein Pept Lett; 2013 Feb; 20(2):205-12. PubMed ID: 22894159
[TBL] [Abstract][Full Text] [Related]
37. Multiplex PCR targeting tpi (triose phosphate isomerase), tcdA (Toxin A), and tcdB (Toxin B) genes for toxigenic culture of Clostridium difficile.
Lemee L; Dhalluin A; Testelin S; Mattrat MA; Maillard K; Lemeland JF; Pons JL
J Clin Microbiol; 2004 Dec; 42(12):5710-4. PubMed ID: 15583303
[TBL] [Abstract][Full Text] [Related]
38. Cytotoxin CctA, a major virulence factor of Clostridium chauvoei conferring protective immunity against myonecrosis.
Frey J; Johansson A; Bürki S; Vilei EM; Redhead K
Vaccine; 2012 Aug; 30(37):5500-5. PubMed ID: 22749595
[TBL] [Abstract][Full Text] [Related]
39. Comparison of VIDAS CDAB and CDA immunoassay for the detection of Clostridium difficile in a tcdA- tcdB+ C. difficile prevalent area.
Shin BM; Lee EJ; Kuak EY; Yoo SJ
Anaerobe; 2009 Dec; 15(6):266-9. PubMed ID: 19772927
[TBL] [Abstract][Full Text] [Related]
40. Analysis of the pathogenicity locus in Clostridium difficile strains.
Cohen SH; Tang YJ; Silva J
J Infect Dis; 2000 Feb; 181(2):659-63. PubMed ID: 10669352
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
